NanoViricides Files Quarterly Report for Period Ending March 31, 2019 - HerpeCideā„¢ Drug Candidate Pre-IND Application Submitted, Progressing Towards Clinical Trials May 20, 2019 07:00AM
NanoViricides (NNVC) Announces $2.5 Million Financing in Registered Direct Offering of Common Stock, Warrants Feb 27, 2019 09:50AM
NanoViricides Announces $2.5 Million Financing in a Registered Direct Offering Feb 27, 2019 09:48AM
Streetinsider.com's Hot Lunchtime Reads 10/9: (NNVC) (PLUG) (CRM) (DYNT) Oct 9, 2014 12:16PM
NanoViricides (NNVC) Restarts Ebola Program; Chardan Capital Maintains 'Buy' Rating Oct 9, 2014 12:11PM


May 8, 2014 09:16AM Chardan Capital Markets Starts NanoViricides (NNVC) at Buy